التاريخ:	--/--/-- --:--:--
مُعرِّف الحدث:	E5LEL6C11
نوع الإجراء:	ACQUISITION
حالة الإجراء:	ANNOUNCED
رمز سهم الشركة المستحوِذة:
الرمز المُستهدَف:	AONC
مُحدَّث:	--/--/-- --:--:--
سعر شراء السهم:
عملة سعر السهم الواحد:
مصادر الأخبار:	https://www.businesswire.com/news/home/20261020319270/en/

ملاحظات حول الإجراء

Cencora, Inc. (NYSE: COR) today announced it has signed a definitive agreement to acquire American Oncology Network, Inc. ("AON") (OTCQX: AONC), a physician-led network of more than 350 oncology providers across 21 states. Cencora currently holds approximately 4% of the equity interests in AON and, under the terms of the transaction, has agreed to acquire all of the equity interests that it does not currently own. The transaction values AON at an enterprise value of $2.4 billion, consisting of $2.3 billion at closing and contingent value rights ("CVRs") of up to $100 million (with the CVRs payable by Cencora upon the satisfaction of certain conditions). The transaction is subject to the satisfaction of customary closing conditions, including receipt of required regulatory clearances and AON stockholder approvals. The agreement has been approved by AON's Board of Directors, acting on the unanimous recommendation of AON's special committee of independent and disinterested directors.